Epizyme, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Epizyme, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | S | 11.21 | 3,890 | 43,607 | 331,977 | 335.9 K to 332 K (-1.16 %) |
| Feb 05 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 11.21 | 969 | 10,862 | 104,341 | 105.3 K to 104.3 K (-0.92 %) |
| Feb 05 2021 | EPZM | Epizyme, Inc. | Vakiener Victoria | Chief Commercial Of ... | Sell | S | 11.21 | 817 | 9,159 | 52,685 | 53.5 K to 52.7 K (-1.53 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Option Exercise | A | 11.02 | 141,135 | 1,555,308 | 141,135 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 29,583 | 0 | 105,310 | 75.7 K to 105.3 K (+39.07 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | A | 11.02 | 417,443 | 4,600,222 | 417,443 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Grant | A | 0.00 | 87,500 | 0 | 335,867 | 248.4 K to 335.9 K (+35.23 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controlle ... | Option Exercise | A | 11.02 | 11,550 | 127,281 | 11,550 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controlle ... | Grant | A | 0.00 | 7,700 | 0 | 13,658 | 6 K to 13.7 K (+129.24 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Off ... | Option Exercise | A | 11.02 | 124,239 | 1,369,114 | 124,239 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Off ... | Grant | A | 0.00 | 26,041 | 0 | 54,486 | 28.4 K to 54.5 K (+91.55 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Vakiener Victoria | Chief Commercial Of ... | Option Exercise | A | 11.02 | 121,754 | 1,341,729 | 121,754 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Vakiener Victoria | Chief Commercial Of ... | Grant | A | 0.00 | 25,520 | 0 | 53,502 | 28 K to 53.5 K (+91.20 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Option Exercise | A | 11.02 | 134,178 | 1,478,642 | 134,178 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Grant | A | 0.00 | 28,125 | 0 | 84,082 | 56 K to 84.1 K (+50.26 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 11.02 | 136,663 | 1,506,026 | 136,663 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Of ... | Grant | A | 0.00 | 28,645 | 0 | 56,057 | 27.4 K to 56.1 K (+104.50 %) |